MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy and light imaging systems, announced today the MoleMate™ Innovator’s Program. MoleMate, the unique FDA approved skin imaging system, previously only sold in the UK and Australia, is now available for sale in the US. The application process has also begun for Health Canada approval. MoleMate uses a hand-held device designed for office use that utilizes light to view beneath suspicious moles in a pain free, non-invasive manner, creating images for physicians to evaluate moles and lesions often eliminating the need for skin biopsies resulting in less pain, scarring, and expense. Physicians interested in learning more should contact their local representative on the web at http://simsys-molemate.com.
